Taro Pharmaceutical
TARO
$38.03
Share price
-0.39%
Change (1 day)
4.77%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - P/B ratio
P/B ratio as of June 2023 : 0.8412
According to Taro Pharmaceutical's latest financial reports the company has a price-to-book ratio of 0.8412.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Taro Pharmaceutical - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 0.6397 | -42.38% |
| 2021-12-31 | 1.11 | -30.82% |
| 2020-12-31 | 1.60 | -2.05% |
| 2019-12-31 | 1.64 | -8.46% |
| 2018-12-31 | 1.79 | -6.1% |
| 2017-12-31 | 1.91 | -11.66% |
| 2016-12-31 | 2.16 | -42.14% |
| 2015-12-31 | 3.73 | -22.32% |
| 2014-12-31 | 4.80 | 2.97% |
| 2013-12-31 | 4.66 | 83.34% |
| 2012-12-31 | 2.54 | 10.51% |
| 2011-12-31 | 2.30 | 41.71% |
| 2010-12-31 | 1.62 | 37.73% |
| 2009-12-31 | 1.18 | -35.87% |
| 2008-12-31 | 1.84 | |
| 2005-12-31 | 1.73 | -35.79% |
| 2004-12-31 | 2.69 | -49.71% |
| 2003-12-31 | 5.35 | 33.85% |
| 2002-12-31 | 4.00 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.31 | 531.35% | 🇺🇸 USA |
 Novartis NVS | 4.02 | 377.92% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.26 | 168.32% | 🇺🇸 USA |
 Merck MRK | 6.20 | 636.90% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 4.99 | 493.69% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.9477 | 12.66% | 🇮🇱 Israel |